C7AHeader code — not billable
Malignant neuroendocrine tumors
- Chapter
- 2. Neoplasms
- Category
- C7A
- Effective date
- October 1, 2026
Related codes in category C7A
C7A.0Malignant carcinoid tumorsC7A.00Malignant carcinoid tumor of unspecified siteYesC7A.01Malignant carcinoid tumors of the small intestineC7A.010Malignant carcinoid tumor of the duodenumYesC7A.011Malignant carcinoid tumor of the jejunumYesC7A.012Malignant carcinoid tumor of the ileumYesC7A.019Malignant carcinoid tumor of the sm int, unsp portionYesC7A.02Malig carcinoid tumors of the appendix, lg int, and rectumC7A.020Malignant carcinoid tumor of the appendixYesC7A.021Malignant carcinoid tumor of the cecumYesC7A.022Malignant carcinoid tumor of the ascending colonYesC7A.023Malignant carcinoid tumor of the transverse colonYes
Frequently asked questions
What is ICD-10 code C7A?
C7A is an ICD-10-CM diagnosis code for Malignant neuroendocrine tumors.
Is C7A a billable code?
No. C7A is a category/header code, not billable on its own — use one of its more specific child codes instead.
What ICD-10-CM chapter is C7A in?
C7A falls under Chapter 2: Neoplasms.
When did C7A become effective?
C7A has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.
What other codes are related to C7A?
C7A belongs to category C7A, which includes 12 other codes — see the related codes list on this page.
ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.